Showing results (1-10 of 1,248) with videos related to
Sort By:
Pageof 125
Human Genetics|July 1, 1993
A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reactionM Armstrong, J R Idle, A K DalyEnvironmental Health Perspectives|November 1, 1994
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibilityA K Daly, S Cholerton, M Armstrong, et al.Pharmacogenetics|April 1, 1994
The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European populationM Armstrong, K Fairbrother, J R Idle, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1997
Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotypeM Armstrong, A K Daly, R Blennerhassett, et al.Annals of the Rheumatic Diseases|January 1, 1996
Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritisC Beyeler, M Armstrong, H A Bird, et al.Lancet (London, England)|April 25, 1992
Mutant debrisoquine hydroxylation genes in Parkinson's diseaseM Armstrong, A K Daly, S Cholerton, et al.Environmental Health Perspectives|October 1, 1993
New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6J R Idle, A K DalyPharmacogenetics|October 1, 1991
Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypesA K Daly, M Armstrong, S C Monkman, et al.The Journal of Rheumatology|June 1, 1994
Phenotype/genotype relationships for the cytochrome P450 enzyme CYP2D6 in rheumatoid arthritis: influence of drug therapy and disease activityC Beyeler, A K Daly, M Armstrong, et al.Trends in Pharmacological Sciences|December 1, 1992
The role of individual human cytochromes P450 in drug metabolism and clinical responseS Cholerton, A K Daly, J R IdlePageof 125